Brovana 15 mcg in 2 mL Inhalation Solution
RxNorm 695935
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 695935 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Brovana 15 mcg in 2 mL Inhalation Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Arformoterol 0.0075 mg/ML Inhalation Solution [Brovana]
(Atom ID: 10788647)
SYPrescribable
Synonym (SY):
Brovana 0.0075 mg/ML (arformoterol tartrate 0.011 mg/ML) Inhalation Solution
(Atom ID: 10788474)
SYPrescribable
Synonym (SY):
Brovana 0.0075 mg/ML Inhalation Solution
(Atom ID: 10788472)
PSNPrescribable
Prescribable Name (PSN):
Brovana 15 mcg in 2 mL Inhalation Solution
(Atom ID: 10789705)
SYPrescribable
Synonym (SY):
Brovana 15 mcg per 2 mL Inhalation Solution
(Atom ID: 10788473)
Patient Education
Arformoterol Oral Inhalation
Arformoterol inhalation is used to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of lung diseases, which includes chronic bronchitis and emphysema). Arformoterol is in a class of medications called long-acting beta agonists (LABAs). It works by relaxing and opening air passages in the lungs, making it easier to breathe.
[Learn More]
* Please review the disclaimer below.